ATE273974T1 - Benzoxazolderivate und medikamente die diese als aktiven wirkstoff enthalten - Google Patents

Benzoxazolderivate und medikamente die diese als aktiven wirkstoff enthalten

Info

Publication number
ATE273974T1
ATE273974T1 AT99972633T AT99972633T ATE273974T1 AT E273974 T1 ATE273974 T1 AT E273974T1 AT 99972633 T AT99972633 T AT 99972633T AT 99972633 T AT99972633 T AT 99972633T AT E273974 T1 ATE273974 T1 AT E273974T1
Authority
AT
Austria
Prior art keywords
group
lower alkyl
alkyl group
medications
contain
Prior art date
Application number
AT99972633T
Other languages
English (en)
Inventor
Sojiro Shiokawa
Yasuo Sato
Masaaki Izumi
Satoshi Yoshida
Hiroshi Meiji Murakami
Tomoko Ito
Tetsutaro Niisato
Original Assignee
Shudo Koichi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shudo Koichi filed Critical Shudo Koichi
Application granted granted Critical
Publication of ATE273974T1 publication Critical patent/ATE273974T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT99972633T 1998-11-20 1999-11-19 Benzoxazolderivate und medikamente die diese als aktiven wirkstoff enthalten ATE273974T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33127498 1998-11-20
PCT/JP1999/006491 WO2000031073A1 (en) 1998-11-20 1999-11-19 Benzoxazole derivatives and drugs containing the same as the active ingredient

Publications (1)

Publication Number Publication Date
ATE273974T1 true ATE273974T1 (de) 2004-09-15

Family

ID=18241866

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99972633T ATE273974T1 (de) 1998-11-20 1999-11-19 Benzoxazolderivate und medikamente die diese als aktiven wirkstoff enthalten

Country Status (23)

Country Link
US (1) US7045516B1 (de)
EP (1) EP1134220B1 (de)
JP (1) JP4557112B2 (de)
KR (1) KR100675033B1 (de)
CN (1) CN1333771A (de)
AT (1) ATE273974T1 (de)
AU (1) AU753797B2 (de)
BR (1) BR9916793A (de)
CA (1) CA2351446A1 (de)
CZ (1) CZ20011700A3 (de)
DE (1) DE69919575T2 (de)
ES (1) ES2222763T3 (de)
HU (1) HUP0104238A3 (de)
ID (1) ID30143A (de)
IL (1) IL143178A0 (de)
NO (1) NO20012443L (de)
PL (1) PL348426A1 (de)
RU (1) RU2204558C2 (de)
SK (1) SK6772001A3 (de)
TR (1) TR200101945T2 (de)
TW (1) TW520370B (de)
WO (1) WO2000031073A1 (de)
ZA (1) ZA200104620B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660858B2 (en) * 2001-03-28 2003-12-09 Lion Bioscience Ag 2-aminobenzoxazole derivatives and combinatorial libraries thereof
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
AU2003252738A1 (en) * 2002-08-09 2004-02-25 Ajinomoto Co., Inc. Remedy for intestinal diseases and visceral pain
US20070010543A1 (en) * 2005-07-01 2007-01-11 Dynogen Pharmaceuticals, Inc. Compositions and methods for treating gastrointestinal hypomotility and associated disorders
MX2008011123A (es) * 2006-03-28 2008-09-30 High Point Pharmaceuticals Llc Benzotiazoles que tienen actividad de receptor h3 de histamina.
US8178666B2 (en) * 2008-10-23 2012-05-15 Albany Molecular Research, Inc. 2-aminobenzoxazole process
KR101579688B1 (ko) 2014-07-08 2015-12-24 재단법인 전남생물산업진흥원 좁쌀풀 추출물을 유효성분으로 함유하는 과민성 대장증후군에 의한 내장 통증 억제예방 또는 치료용 약학 조성물
GEP20247674B (en) * 2020-06-12 2024-09-25 Hk Inno N Corp Pharmaceutical composition comprising benzimidazole derivative compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3193560B2 (ja) * 1993-04-16 2001-07-30 明治製菓株式会社 新規ベンゾオキサゾール誘導体
JP3520177B2 (ja) 1996-05-09 2004-04-19 明治製菓株式会社 セロトニン５−ｈｔ３受容体部分活性薬

Also Published As

Publication number Publication date
HUP0104238A2 (en) 2002-08-28
KR100675033B1 (ko) 2007-01-29
CA2351446A1 (en) 2000-06-02
SK6772001A3 (en) 2001-12-03
US7045516B1 (en) 2006-05-16
KR20010086448A (ko) 2001-09-12
HUP0104238A3 (en) 2003-05-28
AU753797B2 (en) 2002-10-31
ID30143A (id) 2001-11-08
ES2222763T3 (es) 2005-02-01
CZ20011700A3 (cs) 2001-10-17
IL143178A0 (en) 2002-04-21
NO20012443L (no) 2001-07-12
PL348426A1 (en) 2002-05-20
AU1185000A (en) 2000-06-13
EP1134220A1 (de) 2001-09-19
NO20012443D0 (no) 2001-05-18
TR200101945T2 (tr) 2001-11-21
WO2000031073A1 (en) 2000-06-02
TW520370B (en) 2003-02-11
RU2204558C2 (ru) 2003-05-20
ZA200104620B (en) 2002-02-04
EP1134220B1 (de) 2004-08-18
DE69919575D1 (de) 2004-09-23
DE69919575T2 (de) 2005-09-29
JP4557112B2 (ja) 2010-10-06
CN1333771A (zh) 2002-01-30
EP1134220A4 (de) 2001-12-19
BR9916793A (pt) 2001-11-13

Similar Documents

Publication Publication Date Title
DK1213296T3 (da) Glucopyranosyloxpyrazolderivater, lægemidler indeholdende samme samt mellemprodukter til fremstilling heraf
ES2137169T3 (es) Nuevos derivados de tiazolilbenzofurano, procedimientos para su preparacion y composicion farmaceutica que los contiene.
ATE226574T1 (de) 4,6-diarylpyrimidin-derivate und deren salze
ATE358484T1 (de) Antidiabetische medikamente
IL114875A (en) Quinolone or naphthylidone-carboxylic acid derivatives or their salts and pharmaceutical compositions containing them
ATE247089T1 (de) Pyridoncarbonsäurederivate oder ihre salze und diese als aktive bestandteile enthaltende medikamente
ATE273974T1 (de) Benzoxazolderivate und medikamente die diese als aktiven wirkstoff enthalten
EP0779074A4 (de) Wirkstoff zum schutz für organ oder gewebe
ATE525366T1 (de) Benzoxazolderivate und pharmazeutische zubereitungen die diese enthalten
NO20014119L (no) Medikament inneholdende et sulfopyranosylacylglycerolderivat
ATE201404T1 (de) Epoxysuccinamid-derivate oder deren salze und medikamente die diese enthalten
ATE223411T1 (de) 1-methylcarbapenem-derivate
ATE275560T1 (de) Bemzimidazolverbindungen und medikamente die diese enthalten
NO993911L (no) Remedier/Forebygningsmidler for Õndedrettssykdommer
DE60009301D1 (en) Benzimidazolverbindungen
DE60203029D1 (de) Benzopyran Derivate und diese enthaltende Antiallergisches Mittel
TH53245A3 (th) อนุพันธ์เบนซอกซาโซลและยาที่ประกอบรวมด้วยอนุพันธ์ดังกล่าวในฐานะสารออกฤทธิ์

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties